I'm looking for

The Latest in Gynecologic Oncology

The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers. As a 501(c)(6) organization, the SGO contributes to the advancement of women’s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations.

SGO publishes news releases, shares news articles relevant to the subspecialty, position statements in response to current issues in gynecologic oncology and produces special reports to shape the future of gynecologic health.

Category

Jun 4, 2020

SGO/FWC Promotes Sullivan to New COO Role

Author(s): SGO
Categories: Member Update
Jun 2, 2020

SGO Statement on Racism and Violence

Author(s): SGO
Categories: Member Update
May 29, 2020

Society of Gynecologic Oncology recognizes winners of 2020 SGO Awards

Author(s): SGO
Categories: News Releases
May 8, 2020

The Coronavirus Is Mutating. That’s Normal. Does That Mean It’s More Dangerous?

Author(s): NPR
Categories: News Article
May 8, 2020

This Is the Future of the Pandemic

Author(s): New York Times
Categories: News Article
May 8, 2020

COVID-Positive: A Physician’s Diary

Author(s): Medscape
Categories: News Article
May 7, 2020

Community Cancer Practices Battered by Closures, Now COVID-19

Author(s): Medscape
Categories: News Article
May 7, 2020

Dr. David Cohn Starts Tenure as President of Society of Gynecologic Oncology

Author(s): SGO
Categories: News Releases
Apr 27, 2020

Herceptin Boosts OS in HER2-Positive Uterine Cancer

Author(s): Medpage Today
Categories: SGO in the News
Apr 27, 2020

Add-On Metformin No Help in Advanced Endometrial Cancer

Author(s): Medpage Today
Categories: SGO in the News
Apr 24, 2020

Statement of the Society of Gynecologic Oncology to the Food and Drug Administration’s Obstetrics and Gynecology Medical Devices Advisory Committee Concerning Safety of Laparoscopic Power Morcellation

Author(s): SGO
Categories: Morcellation Updates
Apr 13, 2020

Frontline Niraparib Plus Bevacizumab for Advanced Ovarian Cancer Yields Promising Activity

Author(s): Targeted Oncology
Categories: SGO in the News
Apr 13, 2020

Adjuvant HPV vaccination lowers risk for high-grade cervical dysplasia recurrence

Author(s): Healio
Categories: SGO in the News
Apr 11, 2020

Analyses of Frontline Niraparib Maintenance Demonstrate Positive Patient-Reported Outcomes in Ovarian Cancer

Author(s): Targeted Oncology
Categories: SGO in the News
Apr 9, 2020

Progression-Free Survival, Overall Survival Similar Between Olaparib, Chemotherapy

Author(s): Pharmacy Times
Categories: SGO in the News

Join SGO Today

What you get out of membership changes your patient’s lives. What you give from your membership changes the world. Join your community today.

Become a Member